Cataract Surgery Clinical Trial
Official title:
A Prospective, Single Center, Non-comparative, 90-Day Follow-up, Postmarket Clinical Investigation of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
NCT number | NCT03644875 |
Other study ID # | CPH-401-201287 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 28, 2018 |
Est. completion date | May 16, 2019 |
Verified date | August 2019 |
Source | Croma-Pharma GmbH |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a prospective, single center, non-comparative, 90-day follow-up, post-market clinical
investigation of etacoat in patients undergoing cataract surgery.
The performance is evaluated by the preservation of endothelial cells measured by specular
microscopy at the follow-up visit in comparison to baseline values.
Status | Completed |
Enrollment | 40 |
Est. completion date | May 16, 2019 |
Est. primary completion date | May 16, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients indicated for cataract surgery via the anterior chamber - A negative urine pregnany test at Visit 1 or 2 - Capability to understand information about the investigation, including patients' obligations, and willingness to take part, as evidenced by signed and dated informed consent. Exclusion Criteria: - Patient who are known to be hypersensitive to HPMC or other components of the device - Patients with corneal scars or corneal dystrophies interfering with study measurements - Abnormal intraocular pressure which would interfere with surgery and follow up (in opinion of the investigator) - Any other condition that in the opinion of the investigator would interfere with the participation in this investigation - Any person dependent on the investigator or employees of the investigation site institution or the Sponsor - Current or previous (within 30 days of enrollment) treatment with another investigational drug and/or medical device or participation in another clinical study - Patients whose participation in clinical trials is prohibited by the Austrian Medical Devices Act |
Country | Name | City | State |
---|---|---|---|
Austria | Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital | Vienna |
Lead Sponsor | Collaborator |
---|---|
Croma-Pharma GmbH |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Specular microscopy to measure the preservation of endothelium | 90 days post surgery compared to baseline | ||
Secondary | Specular microscopy to measure the corneal thickness | post surgery, 1 day and 90 days post surgery compared to baseline | ||
Secondary | Intraocular pressure measurement | post surgery, 1 day and 90 days post surgery compared to baseline | ||
Secondary | Questionnaire to assess the satisfaction with the application | Questionnaire contains the subjective evaluation by the investigator of the IMD's rheological properties as well as the maintenance of the patient's anterior chamber and dome. Scale for the chamber and dome maintenance ranges from flat (worst case) to full chamber (best case) maintained. Scale for rheological properties ranges from dispersive (best case) to cohesive (worst case). |
day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02573610 -
Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
|
Phase 3 | |
Completed |
NCT02910362 -
Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines
|
N/A | |
Recruiting |
NCT01193504 -
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
|
Phase 4 | |
Completed |
NCT01455233 -
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
|
Phase 4 | |
Completed |
NCT01199510 -
Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery
|
Phase 4 | |
Completed |
NCT04146961 -
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
|
||
Completed |
NCT00585975 -
Efficacy and Safety of Bromfenac Ophthalmic Solution
|
Phase 2 | |
Completed |
NCT00406913 -
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
|
N/A | |
Not yet recruiting |
NCT04131335 -
Use of Prophylactic Lubricating Drops After Cataract Surgery
|
N/A | |
Recruiting |
NCT05331690 -
Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN)
|
Phase 4 | |
Withdrawn |
NCT04563559 -
PREFERENTIAL Study
|
Phase 2/Phase 3 | |
Completed |
NCT04732351 -
Evaluation of the Active Sentry System During Cataract Surgery With the Centurion Phacoemulsifier
|
||
Completed |
NCT02128113 -
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
|
Phase 2 | |
Completed |
NCT03873454 -
The Effects of Music on Perioperative Outcomes in Cataract Surgery
|
N/A | |
Completed |
NCT04769856 -
Impact of Non-fasting on Anxiety in Cataract Surgery
|
N/A | |
Withdrawn |
NCT00604305 -
Comperative Trial Between an Accommodative Iol and Monofocal Iol
|
N/A | |
Completed |
NCT05925894 -
Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.
|
N/A | |
Not yet recruiting |
NCT06136780 -
Impact of Free Reading Glasses on Work and Visual Function Following Cataract Surgery in Honduras
|
N/A | |
Completed |
NCT04633954 -
Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery
|
N/A | |
Recruiting |
NCT04781231 -
Impact of Music Added to the Usual Treatment on the Anxiety of Patients Undergoing Outpatient Cataract Surgery With Topical Anesthesia
|
N/A |